Abslraer: Two polyhydroxylated quinolizidincs, (lR,2R,3R,9S,9aR>1,2,3,9-teaahydroxyquinolizidine 9 and (1R,2R,33R,9R,9aYJ-1,2,3,9-tetrabydroxyquinolizidine 10, have been synthesized by the reductive double cycliiation of 1% and 15fS. Quinolizidine 9 can be viewed either as a ring expanded analog of 6-epicastanospermine or of 8-episwainsonine, while 10 is a ring expanded analog of 1,6,8a-triepicastanospzmhe or of zla-episwainsonine. Considerable effort has been put forth by a number of researchers to investigate the structure-activity relationships of the polyhydroxylated indolizidines, resulting in the synthesis of many of the stereoisomers of castanospermine 1 and swainsonine 2 for biological evaluation. 2.3 Stereoisomers of polyhydroxylated pyrrolizidines (e.g. alexine 5 and australine) as well as ring contracted versions of polyhydroxylated indolizidine alkaloids have also been prepared and in some cases evaluated for inhibitory activity. The key step in the synthesis of 9 and 10 is the efficient formation of the quinolizidine ring system via a reductive double alkylation of an azido-epoxide that possesses an o-leaving group (Scheme 1). We&l7 and others4avd*8 have previously employed a similar strategy to assemble pyrrolizidine and indolizidine ring systems.
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Scheme 1
Our synthesis began with 2,3,4-tri-O-benzyl-D-arabinopyranose 11, which was prepared from D-arabinose in three steps according to Fletcher's procedure (Scheme 2).9 Wittig olelination of 11 with the chloro-substituted phosphonium salt 1210 selectively yielded the (Z)-chloroalkenoll3 in 7 1% yield, which was then converted to azide 14 in 84% yield using the Mitsunobu method.11 Epoxidation of 14 with m-CPBA produced an inseparable mixture of epoxides 15a and 158 (2.5 : 1) in 88% (a and 8 refer to the orientation of the epoxide oxygen). Reduction of the mixture of azido-epoxides 15cdlSp to amino-epoxides 16crI16p without debenzylation was accomplished under mild Pd-catalyzed hydrogenolysis conditions. The amino compounds 16cz/16f~ were not purified, but were heated in refluxing ethanol containing K2CO3 to produce a mixture of quinolizidines 17 and 18 (2.5 : 1) in 65% from 15a/lSg. Compounds 17 and 18 separated (Siti) and their stereochemistries were assigned by examination of rH NMR coupling constants.12 The stereochemistry of the major isomer 17 implies that 15~ is the major product of the epoxidation reaction. Debenzylation of 17 and 18 was carried out under more rigorous Pd-catalyzed hydrogenolysis conditions to yield respectively (lRJR,3R,9S.9aR)-1,2,3,9-tetrahydroxyquinolizidine 9 in 99% and (lR,2R,3R,9R, 9aS)-1,2,3,9-tetrahydroxyquinolizidine 10 in 92%.13
Screening for glycosidase inhibitory activity is underway and will be reported with a full account of this work. Acknowledgement We thank the National Institutes of Health (GM-35572) for support of this research.
1.
2.
3.
4.
5.
6. 7.
8.
9.
10.
11.
12.
13. 
NOTES AND REFERENCES

